Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple … (NCT03632473) | Clinical Trial Compass
CompletedNot Applicable
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
Switzerland29 participantsStarted 2014-08-28
Plain-language summary
Utility of Multimodal Evoked potentials (mmEP) for monitoring disease course and prediction of progression at different stages of Multiple Sclerosis (MS) is investigated
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* diagnosed with a clinically isolated syndrome (CIS) or MS with a relapsing-remitting (RRMS) or a primary progressive disease course (PPMS):
* CIS: EDSS \<= 5.5 within six months of first clinical event
* early RRMS: EDSS: \<= 3.5 disease course of 5 up to 10 years
* late RRMS: EDSS: 2.0-5.5 inclusive disease course of 5 to 15 years
* PPMS: EDSS: 2.0-6.5 inclusive disease course up to 15 years
* participation in the Swiss Multiple Sclerosis Cohort Study (SMSC)
* mental ability to cooperate
* written informed consent
Exclusion Criteria:
* alcohol or substance abuse
* progressive disease other than Multiple Sclerosis
* psychiatric disorder requiring a treatment by a psychiatrist
* patients with movable metal implants, e.g. pace-maker, stents, deep brain stimulators etc.;(patients with jaw- or bone-fixed metal implants can be included)
What they're measuring
1
correlation of EP-sum-score (Σ-EP) and the Expanded Disability Status Scale (EDSS)